HMGB1 and neoplasm: Furthermore, at 42 days post-injection, the tumor volume was notably reduced in mice treated with the HMGB1 inhibitor glycyrrhizin (group IV, U87 + shNC + glycyrrhizin) compared to the untreated group (group II, U87 + shNC) (Fig. 8A-B).